Cargando…
Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study
SIMPLE SUMMARY: To investigate the organ-specific responses and clinical outcomes of mixed responses (MRs) to treatment with pembrolizumab for unresectable or metastatic urothelial carcinoma (ur/mUC), 136 patients were analyzed retrospectively. The total objective response rate (ORR) and organ-speci...
Autores principales: | Shimizu, Takuto, Miyake, Makito, Nishimura, Nobutaka, Inoue, Kuniaki, Fujii, Koyo, Iemura, Yusuke, Ichikawa, Kazuki, Omori, Chihiro, Tomizawa, Mitsuru, Maesaka, Fumisato, Oda, Yuki, Miyamoto, Tatsuki, Sakamoto, Keiichi, Kiba, Keisuke, Tanaka, Masahiro, Oyama, Nobuo, Okajima, Eijiro, Fujimoto, Ken, Hori, Shunta, Morizawa, Yosuke, Gotoh, Daisuke, Nakai, Yasushi, Torimoto, Kazumasa, Tanaka, Nobumichi, Fujimoto, Kiyohide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997142/ https://www.ncbi.nlm.nih.gov/pubmed/35406508 http://dx.doi.org/10.3390/cancers14071735 |
Ejemplares similares
-
Unexpected presentation of allograft dysfunction triggered by page kidney phenomenon immediately after kidney transplantation: a case report
por: Hori, Shunta, et al.
Publicado: (2018) -
Is Endoscopic Transurethral Incision Really Effective for Boys with Refractory Daytime Incontinence?
por: Morizawa, Yosuke, et al.
Publicado: (2020) -
A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future ‘MRI-PDD Fusion TURBT’
por: Miyake, Makito, et al.
Publicado: (2019) -
Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancer
por: Iemura, Yusuke, et al.
Publicado: (2023) -
Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
por: Nishimura, Nobutaka, et al.
Publicado: (2022)